Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose
PaperCitations, authors & open-access status
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 116 citations, 2021 year and closed oa status.
116
Citations
2021
Year
closed
OA Status